You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Prognostic Factors and Survival Patterns in Pediatric Low-grade Gliomas Over 4 Decades

Youland, Ryan S. BS*; Khwaja, Shariq S. MD, PhD*; Schomas, David A. MD; Keating, Gesina F. MD; Wetjen, Nicholas M. MD§; Laack, Nadia N. MD, MS*

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182678bf8
Original Articles
Abstract

Background: This study reports changes in long-term survival after the introduction of modern imaging in pediatric patients with low-grade gliomas (LGGs).

Methods: Records from 351 consecutive pediatric patients diagnosed with LGG between 1970 and 2009 at Mayo Clinic Rochester were reviewed and divided into diagnosis before (group I: 1970 to 1989) and after (group II: 1990 to 2009) postoperative magnetic resonance imaging became regularly used in pediatric LGG.

Results: Median progression-free survival (PFS) and overall survival (OS) were not reached. Overall, 10-year PFS was 62% and OS was 90%. On multivariate analysis, improved PFS was associated with gross total resection (GTR; P<0.0001) and postoperative radiation therapy (RT; P<0.0001). In those undergoing less than GTR, PFS was improved with RT, nearing rates of patients receiving GTR (P=0.12). On multivariate analysis, higher OS was associated with GTR (P<0.0001) and pilocytic histology (P=0.03). Group II had fewer headaches, fewer sensory/motor symptoms, less postoperative RT, and more GTRs. OS and PFS were not different between the groups.

Conclusions: This large series of pediatric LGG patients with long-term follow-up found no significant changes in OS or PFS over time. Overall, GTR was associated with improved OS and PFS. RT was associated with an improvement in PFS, with the greatest benefit seen in patients undergoing less than GTR.

Author Information

Departments of *Radiation Oncology

Child and Adolescent Neurology

§Neurosurgery, Mayo Clinic, Rochester, MN

Department of Radiation Oncology, Saint Luke’s Cancer Institute, Kansas City, MO

The authors declare no conflict of interest.

Reprints: Nadia N. Laack, MD, MS, Department of Radiation Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905 (e-mail: laack.nadia@mayo.edu).

Received February 6, 2012

Accepted June 30, 2012

© 2013 Lippincott Williams & Wilkins, Inc.